Off-Label

Physician defends use of antipsychotics for dementia patients in nursing homes

In response to a recent report from the Office of the Inspector General, a prominent psychiatrist is defending the practice of prescribing antipsychotic medications for nursing home residents with dementia.

AstraZeneca settles for $520 million following investigation into improper marketing of anti-psychotic drug

Pharmaceutical giant AstraZeneca has agreed to pay $520 million to end a federal investigation into its alleged illegal marketing of the drug Seroquel for off-label uses, according to reports from Washington.

Many doctors unknowingly prescribe drugs 'off-label,' study finds

A large number of physicians don't know when they are prescribing drugs, including antipsychotics, "off-label," according to a recent report.